Revenue
2015
2017
2019
2021
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $377,000 | $108,000 | $300,000 | — | $500,000 | — | $112,000 | — | $5,000 | — | $25,998 |
| Gross profit | $179,000 | $37,000 | $27,000 | — | $500,000 | — | $7,000 | −$5,111 | $259 | — | $16,342 |
| Research & development | $104,000 | $157,000 | $3,000 | $20,000 | $14,000 | — | $75,000 | — | — | $4,740 | $508 |
| Operating expenses | — | — | — | — | — | — | $135,543 | $100,560 | $109,853 | $268,268 | $297,934 |
| Operating income | −$1.2M | −$1.0M | −$802,000 | −$1.1M | −$442,000 | −$1.3M | −$1.0M | −$105,671 | −$109,594 | −$268,268 | −$281,592 |
| EBITDAderived | $1.8M | $2.0M | — | −$1.1M | −$439,000 | −$1.3M | −$1.0M | — | — | — | — |
| Net income | −$1.2M | −$985,000 | −$726,000 | −$1.1M | −$888,000 | −$1.4M | −$1.1M | −$142,324 | −$149,056 | −$299,174 | −$299,927 |
| Basic EPSper diluted share | -$0.57 | -$0.45 | -$0.02 | -$0.06 | -$0.02 | -$0.04 | -$0.04 | -$0.12 | -$0.13 | -$0.26 | -$0.34 |
| Diluted EPSper diluted share | -$0.57 | -$0.45 | -$0.02 | -$0.06 | -$0.02 | -$0.04 | -$0.04 | -$0.12 | -$0.13 | -$0.26 | -$0.34 |